New hope for head and neck cancer patients in experimental drug trial
Disease control
Recruiting now
This study is testing whether adding an experimental drug called VS-101 to standard chemoradiation treatment works better for adults with head and neck cancer. It will involve about 30 participants to see if the combination helps control the cancer longer and is safe. The main go…
Phase: PHASE2 • Sponsor: VSPharmTech Co.,Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC